Anavex Life Sciences Corp. (AVXL) stock
AVXLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
$0.72−0.02 (-2.78%)
Close on Nov 18, 2026Market cap $66.69MP/E –Yield –
Anavex Life Sciences total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
For fiscal 2015 it was $332, down 100.0% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2015 | Sep 30, 2015 | $332 | -100.0% |
| FY2014 | Sep 30, 2014 | $5.72M | – |
See a number that looks wrong?